| For medical practitioners and osteopaths - Osteopathy Journal Articles Catalog. |
|
|
|
|
||
|
|
||
|
|
| First Page | Previous Page | Next Page | Last Page |
| The hazards of chiropractic and osteopathic treatment. Hipp, E. (1961), Med Klin 56: 1020-2. |
| The importance of the metacarpal bone index in the evaluation of uremic osteopathy Cakalaroski, K., D. Katic-Cakalaroska, et al. (1996), Srp Arh Celok Lek 124 Suppl 1: 112-4. Abstract: 71 patients with chronic renal failure were analysed. The patients were treated (N1 = 32) and not treated (N2 = 39) with chronic intermittent hemodialysis. In all analysed patients and in the control group of 20 patients sex and age matched to the examined groups) the outside (D) the inner diameter of the middle II metacarpal bone of the dominant hand was measured (a precision of 0.1 mm was reached using Yashio, Japan, magnifying glass) and the following "metacarpal" indexes were calculated: 1. Garn's Index:--thickness in the cortical bone in mm (D-d) 2. Nordin's score:--percentage of the cortical bone formula: see text 3. Garw's area:--cortical bone surface formula see text 4. The quantity of the corical bone thickness and the bone surface formula: see text From the results received by the analysis it could be noted that the tested patients with chronic renal failure, regardless of chronic intermittent chronic dialyses, showed a negative interdependence on the relation: "PTH-metacarpal index", that indicates the conclusion that the bone destruction is greater if the levels of plasma C-iPTH are higher. The similar can be noticed with the comparison of the C-iPTH-value of the periostitic lacunas in the cortex of the iliac bone (r = 0.64, i.e. higher concentration of C-iPTH agrees with larger surface of lacunar periostitis). Finally, the thickness of the outer cortex of the iliac bone is smaller if the values of C-iPTH are higher (r = 0.12, patients treated with hemodialysis). |
| The osteopathic and chiropractic cults in the United States of America. Wilde, H. (1955), Dtsch Med Wochenschr 80(27-8): 1056-7. |
| The osteopathic idea; its significance in dentistry Llorens, C. (1982), Inf Dent 64(37): 3583-615. |
| The osteopathy of hemochromatosis. Clinical and biological study Sabando, P., L. Miravet, et al. (1973), Rev Clin Esp 129(6): 545-50. |
| The present relationship of osteopathy and scientific medicine. Pollock, W. (1962), World Med J 9: 337-9. |
| The problem of a peculiar osteopathy of the spine in ankylosing spondylitis Pohl, W. and P. Vittali (1969), Verh Dtsch Ges Rheumatol 1: 57-9. |
| The role of aluminum-induced inhibition of the intestinal absorption of calcium in the pathogenesis of aluminum osteopathy Blahos, J., A. D. Care, et al. (1989), Ann Endocrinol (Paris) 50(1): 40-3. Abstract: The aim of the study was to investigate the effect of aluminium on duodenal calcium absorption, the impairment of which can represent a pathogenic factor in the development of aluminium bone lesions. The authors investigated in the chick the effect of Al(OH)3 administered orally and of AlCl3 administered subcutaneously on the duodenal absorption of 47Ca, on serum concentration of calcium, phosphorous, aluminium and 1,25-dihydroxycholecalciferol and on bone morphology. Oral administration of Al(OH)3 for 8, 15, and 22 days was without any significant change. Subcutaneous administration of Al/Cl/3 for 8 day was associated with a significant increase in serum aluminium and 1,25-dihydroxycholecalciferol levels and with a significant decrease of the duodenal absorption of 47Ca. Decreased intestinal absorption of calcium may play a pathogenic role in the development of aluminium osteopathy. Increased serum 1,25-dihydroxycholecalciferol reflects presumably a compensatory mechanism of the lowered calcium absorption. |
| The signs of renal osteopathy seen on chest radiographs (author's transl) Hauswaldt, C. and G. Wolf (1974), Fortschr Geb Rontgenstr Nuklearmed 120(2): 186-91. |
| The value of scintimetry compared with histomorphology, parathormone assay, densitometry and radiology in renal osteopathy (author's transl) Lingg, G., G. Nebel, et al. (1982), Rofo 136(1): 9-13. Abstract: The distribution of 99mTc-Sn-MDP in the thigh was estimated according to two different indices in 60 normal patients, 21 patients undergoing haemodialysis and one who had had a renal transplant. Deviation of the indices in these patients from the normal are significant. The indices were correlated with respect to their accuracy in detecting renal osteopathy with histomorphometry (as the reference method), radiological diagnosis, densitometry, parathormone assay and other laboratory tests. Accuracy of the method is high and, like histomorphometry, is over 90%. |
| Therapy of renal osteopathy Schulz, W. (1978), Dtsch Med Wochenschr 103(51): 2025-7. |
| Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency von Herrath, D., D. Kraft, et al. (1973), Dtsch Med Wochenschr 98(28): 1379-81. |
| Therapy of uremic osteopathy Mehls, O. (1975), Monatsschr Kinderheilkd 123(12): 774-6. |
| Therapy of uremic osteopathy Schaefer, K. (1980), Dtsch Med Wochenschr 105(48): 1670-1. |
| Therapy success in the treatment of severe renal osteopathy as the result of effective interdisciplinary team work. Case report Engelmann, L., J. Gummel, et al. (1990), Beitr Orthop Traumatol 37(3): 172-6. Abstract: Report about therapy of a severe renal osteopathy, a case of tertiary hyperparathyroidism. It will be shown the good team work between paediatrics, surgery and orthopaedics. Only on this way the patient get the ability for a later dialysis or kidney transplantation. |
| Thevenard ulcero-mutilating acro-osteopathy syndrome Kind, R. (1976), Z Hautkr 51(21): 927-32. Abstract: A 20-year old female patient with characteristic symptoms of acroosteolysis of the left foot (sensory neuropathy, ulcers and hyperkeratosis on the acra, acroosteolysis and peroneal muscleatrophy) is described. The syndrome manifested in early childhood, heridity could not be found. Correspondence to the familial type of acroosteolysis (of Thevenard) as a new mutation is discussed. |
| Thyreotoxic osteopathy Zweymuller, K. and H. Jesserer (1973), Minerva Med 64(91): 4830-5. |
| Thyrotoxic osteopathy Zweymuller, K. and H. Jesserer (1973), Cah Med 14(14): 1117-22. |
| Total condensing and hypertrophic osteopathy of a rib in a young boy. A, J. d. B. (1950), J Radiol Electrol Arch Electr Medicale 31(3-4): 165-7. |
| Treatment of aluminum-induced osteopathy with desferrioxamine in dialysis-dependent renal failure Lechleitner, P., R. Gmeiner, et al. (1987), Wien Med Wochenschr 137(14-15): 355-60. Abstract: Presenting two patients on long-term dialysis with marked osteopathy due to aluminium intoxication we described the symptoms, pathogenesis and therapy of the disease. Two patients were treated with the chelating agent desferrioxamine which lead to a striking improvement in clinical symptoms and removal of aluminium from bone. Osteopathy due to aluminium intoxication is refractory to Vitamin D and its metabolites. Using reversed osmosis in dialysis the high aluminium levels in bone result mainly from the long-term use of phosphate binders. Therapy of choice is the treatment with desferrioxamine. |
| Treatment of renal osteopathy with 5,6-trans-25-hydroxycholecalciferol (author's transl) Kraft, D., K. Schaefer, et al. (1979), Dtsch Med Wochenschr 104(48): 1706-10. Abstract: The influence of 5,6-trans-25-hydroxycholecalciferol on renal osteopathy was investigated in a total of 132 patients in 26 dialysis centres. Various doses were used, the average being 4000-6000 IU/day. In 32 patients a daily dose of 6000-9000 IU was used. The average individual duration of treatment was 276 days with a maximum of 910 days. Histologically there was an improvement in the renal osteopathy in 55.9% of evaluable cases (n = 34) and in 25.3% there was no deterioration. Radiographically these results were found in 21% and in 70.5% of evaluable cases (n = 105). Serum calcium increased in 46.6% of cases (n = 131), remained the same in 32.8% and decreased in 20.6%. The changes in alkaline phosphatase were similar: it dropped in 42.1% of patients, remained the same in 28.1% and rose in 29.8%. Immunoreactive parathormone which was invariably raised at the beginning of treatment (n = 36), fell in 25.0%, remained the same in 44.4% and rose further in 30.6%. The clinical symptoms of renal osteopathy which had been present in 57 patients improved in 51.0%, remained the same in 46.0% and deteriorated in 3.0%. Signs of intolerance and side effects were rare. Severe hypercalcaemia did not occur. |
| Treatment of renal osteopathy Binswanger, U. (1974), Schweiz Med Wochenschr 104(27): 965-7. |
| Treatment of renal osteopathy Binswanger, U. (1989), Schweiz Med Wochenschr 119(31-32): 1089-94. Abstract: Renal osteodystrophy is defined in the light of bone histology and the clinical and roentgenologic signs are described. Knowledge of the pathogenetic relationships, though incomplete, serves as the basis for the therapy program outlined. |
| Treatment of renal osteopathy Keller, F., A. Schwarz, et al. (1985), Fortschr Med 103(10): 268-70. |
| Treatment of tumor osteopathy in cancer of the prostate Alcover, J., M. Fernandez-Conde, et al. (1994), Actas Urol Esp 18 Suppl: 409-16. Abstract: Some 40% of patients with prostate cancer present with disseminated disease at the time of diagnosis and up to 80% of the total will develop bone dissemination during the disease. The aging of the population and the elevated incidence of prostate cancer (13% of malignancies in males) bring the figure of prostate cancer diagnosed in Europe to 85,000 new cases every year. To begin with, a comment on the overall aspects of bone metastasis from prostate cancer such as incidence, development mechanisms, distribution, prognosis and clinical outcome is made placing special emphasis on the grading and the evaluation of major therapeutical regimes for this kind of patients. Bone metastasis are the most frequent cause of pain due to cancer and are also the cause of immobilization, pathological fractures, bone marrow affectation, medullary compression and sometimes hypercalcemia. It is obvious that any comprehensible therapeutical approach must be multidisciplinary. |
| Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency von Herrath, D., D. Kraft, et al. (1974), MMW Munch Med Wochenschr 116(37): 1573-8. |
| Tuberous sclerosis of the lungs with marked hypertophic pulmonary osteopathy. Wagner, A. and J. Schaaf (1962), Fortschr Geb Rontgenstr Nuklearmed 96: 508-14. |
| Tumor simulating manifestations of renal osteopathy: differential diagnosis and follow-up clinical examples Ewerbeck, V., W. Huber, et al. (1993), Z Orthop Ihre Grenzgeb 131(5): 437-45. Abstract: The course of renal osteodystrophy possibly includes changes, which can mistakenly considered malignant. Especially dialysis-associated tumoral calcinosis may mislead to an inadequate aggressive surgical procedure. Spontaneous involution of these lesions takes place after subtotal parathyroidectomy. Brown tumors subsequent secondary hyperparathyroidism are extremely rare. During maintenance hemodialysis frequently appearing intraosseous cysts develop secondary to beta-2-microglobulin-amyloidosis. Surgery only should be performed in case of occurring pathologic fractures. Other cases are treated conservatively under continuous nephrologic supervision. |
| Tumorous osteopathy and tumorous hypercalcemia Thiebaud, D. and P. Burckhardt (1990), Internist (Berl) 31(12): 756-62. |
| Ulcero-mutilating acro-osteopathy in hereditary neuropathies. Differential diagnosis and pathogenesis Garbe, C., H. P. Vogel, et al. (1989), Dtsch Med Wochenschr 114(16): 628-32. Abstract: Two patients, aged 51 and 70 years, had indolent ulcerations at the sole of the foot with destructive osteolysis in the bones of the feet, lesions characteristic of mutilating ulcerative acro-osteopathy. Patient 1, who had pes cavus, developed ulcerations on the balls of the feet along the second metatarsal bones, and patient 2 with pes equinovarus developed ulcers in the area of the calcaneus. Sock-like hypesthesia/hypalgesia from the toes to the ankles was present in both patients, and electrophysiological tests confirmed the presence of axonal sensory-motor neuropathy. Diabetes mellitus and alcohol abuse was excluded in both patient. Clinical findings, history and neurological disturbances in both patients identified the disease as hereditary sensory neuropathy (type I). |
| Uncommon anatomo-radiological and clinical aspects of Paget's osteopathy. Presentation of an unusual case with calcaneal localization of the disease Barbieri, L. and G. Palminteri (1968), Minerva Ortop 19(5): 247-51. |
| Unique form of osteopathy in neurodystrophic lesions Ermachenko, B. A. (1983), Vestn Rentgenol Radiol(3): 35-40. |
| Unlawful use of a medical title, doctor of osteopathy. Gubler, E. (1958), Schweiz Med Wochenschr 88(37): 910. |
| Unusual case of hypertrophic polyostotic osteopathy Trinchi, E. and R. Aldegheri (1973), Clin Ortop 24(4): 256-67. |
| Unusual course of renal osteopathy with Paget's disease and aluminum deposits Ringe, J. D. and G. Delling (1985), Dtsch Med Wochenschr 110(11): 411-5. Abstract: In a woman with chronic renal failure due to interstitial nephritis after chronic analgesic abuse, secondary hyperparathyroidism was at first the predominant feature during a one-year period of dialysis. After parathyroidectomy severe aluminium-induced osteomalacia dominated the picture in the final phase. Surprisingly hyperparathyroidism recurred despite removal of all glandular tissue, and there also developed--previously undescribed--Paget's disease. |
| Unusual form of diabetic osteopathy: painless fracture of the calcaneus with inflammation of the soft tissues De Leeuw, I., L. Noeninckx, et al. (1974), Acta Clin Belg 29(6): 400-4. |
| Uremic osteopathy in chronic nephritis Sakal, V. and A. Sakalova (1970), Z Urol Nephrol 63(1): 21-5. |
| Uremic osteopathy in dialysis and transplantation with reference to bone scanning Bahlmann, J., A. Gisbertz, et al. (1974), Verh Dtsch Ges Inn Med 80: 736-8. |
| Uremic osteopathy. Clinical, histological, radiological and radioisotope study Zucchelli, P., M. Fusaroli, et al. (1975), Minerva Nefrol 22(2-3): 109-18. |
| Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results Cremer, W., N. Graben, et al. (1977), Verh Dtsch Ges Inn Med 83: 1307-10. |